GlaxoSmithKline
Hikma’s Advair generic delayed in the US
March 12, 2018Sales and Marketing Advair, FDA, GSK, GlaxoSmithKline, pharma
Hikma Pharmaceuticals has been knocked back with the news that the FDA has delayed approval of its generic lung treatment …
The future is now: The transformative power of AI
February 5, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing AI, Exscientia, GSK, GlaxoSmithKline, artificial intelligence, drug development, pharma
With the technologies reaching exciting levels of maturity and adoption, Matt Fellows investigates how AI and machine learning can be …
EMA committee recommends seven therapies from Roche, GSK, MSD and more
January 29, 2018Sales and Marketing Biocon, Chiesi, Chugai, GSK, GlaxoSmithKline, MSD, Mylan, Roche, Sanofi, pharma
The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has voiced its recommendation of a raft of …
GSK wins case against Reckitt Benckiser over misleading ad campaign
January 23, 2018Manufacturing and Production, Sales and Marketing GSK, GlaxoSmithKline, Nurofen, Panadol, Reckitt Benckiser, ibuprofen, paracetamol, pharma
GlaxoSmithKline is celebrating as it emerges that the UK pharma giant triumphed in its legal battle against Reckitt Benckiser after …
GSK Consumer Healthcare announces new Asia Pacific Regional Head
January 16, 2018Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing GSK, GlaxoSmithKline
GlaxoSmithKline’s Consumer Healthcare business has revealed that Filippo Lanzi is to take over as Regional Head of Asia Pacific, overseeing …
NICE recommends first overseas treatment for use on NHS with GSK ‘bubble baby’ gene therapy
January 4, 2018Sales and Marketing ADA-SCID, GSK, GlaxoSmithKline, NHS, NICE, Strimvelis, bubble baby, pharma
NICE has chalked up a new first in its assessment of treatments for use on the NHS, ruling that the …
GSK forced to pay back £1.5m to Scottish Government after recent job cuts
December 20, 2017Manufacturing and Production, Research and Development GSK, GlaxoSmithKline, pharma
British pharmaceutical giant GlaxoSmithKline has been ordered to pay back £1.5 million to the Scottish Government because of its failure …
GSK’s experimental multiple myeloma scores Breakthrough designation with FDA
November 3, 2017Medical Communications, Research and Development, Sales and Marketing Cancer, FDA, GSK, GlaxoSmithKline, multiple myeloma, pharma
GlaxoSmithKline is celebrating the FDA’s decision to award its experimental therapy GSK2857916 with Breakthrough Therapy Designation as a monotherapy in …
GSK’s ‘bubble boy’ gene therapy secures NICE recommendation despite high cost
October 25, 2017Research and Development, Sales and Marketing GSK, GlaxoSmithKline, Strimvelis, pharma
GSK has received good news from NICE as it is revealed that Strimvelis, its gene therapy treatment for adenosine deaminase …
AZ tops annual R&D spend in UK, Roche is greatest pharma spender worldwide
October 24, 2017Manufacturing and Production, Research and Development, Sales and Marketing AstraZeneca, GSK, GlaxoSmithKline, R&D, Roche, pwC
New findings of a report by PwC have revealed the biggest spenders in R&D worldwide as global spending hits $700 …
GSK continues restructure by axing £350m Cumbria plant plans
July 21, 2017Manufacturing and Production, Medical Communications GSK, GlaxoSmithKline, UK, biotech, drugs, pharma, pharmaceuticals
Just days after UK pharma giant GSK announced it would be selling off its Horlicks brand to focus on its …
GSK’s new President of Global Pharma join date revealed as AZ drops lawsuit
June 20, 2017Business Services, Manufacturing and Production AZ, AstraZeneca, GSK, GlaxoSmithKline, Luke Miels
The transition of former AstraZeneca Executive Vice President for Europe Luke Miels to rival pharma giant GlaxoSmithKline has not been …
AZ launches lawsuit against former executive for defecting to GSK
May 17, 2017Manufacturing and Production, Research and Development AZ, AstraZeneca, GSK, GlaxoSmithKline
AstraZeneca has launched a lawsuit against one of its former executives after he jumped ship to join rival pharma giant …
GSK unveils strong showing for twin-drug HIV treatment
February 14, 2017Manufacturing and Production, Research and Development GSK, GlaxoSmithKline, HIV, Tivicay
GlaxoSmithKline has announced strong Phase 3 findings for its own Tivicay (dolutegravir) as part of a twin-drug regimen with J&J’s …
FDA removes black box warning on Pfizer’s anti-smoking medication
December 19, 2016Medical Communications, Sales and Marketing GlaxoSmithKline, Pfizer, anti-smoking, nicotine, smoking
The FDA has decided to remove the “black box” warning upon Pfizer’s anti-smoking drug, Chantix, basing its decision upon the …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
